NCT07137039View on ClinicalTrials.gov

Neoadjuvant Treatment of Locally Advanced Hypopharyngeal Cancer With Adebrelimab Combined With TP Chemotherapy Regimen

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

August 20, 2025

Primary Completion Date

August 20, 2027

Study Completion Date

August 20, 2028

Conditions
Locally Advanced Hypopharyngeal Cancer
Interventions
DRUG

Adebrelimab+Albumin paclitaxel +Cisplatin

"1. Adebrelimab：1200mg, ivgtt, D1, Q3W;~2. Albumin paclitaxel :260mg/m2, ivgtt, D1, Q3W;~3. Cisplatin :60mg/m2, ivgtt, D1, Q3W."

Trial Locations (1)

361003

The First Affiliated Hospital of Xiamen University, Xiamen

All Listed Sponsors
lead

The First Affiliated Hospital of Xiamen University

OTHER